<DOC>
	<DOCNO>NCT02136862</DOCNO>
	<brief_summary>There limit publish clinical data natural history renal disease Alport syndrome . The RG012-01 study collect data characterize progression renal dysfunction Alport syndrome patient . Patients confirm diagnosis Alport syndrome qualify GFR consider enrollment . The sequential sampling subject ' urine and/or blood allow assessment rate change establish clinical endpoint , GFR and/or rate change renal biomarkers ( proteinuria Î²-2 microglobulin ) subject whose renal function steadily decline . The identification surrogate marker track decline renal function could correlate time end-stage renal disease ( ESRD ) key goal natural history study .</brief_summary>
	<brief_title>ATHENA : Natural History Disease Study Alport Syndrome Patients</brief_title>
	<detailed_description>This natural history study , design collect data patient Alport syndrome qualify GFR . Assessments blood urine sample collection perform Baseline every 12 week thereafter , 120 week . Scheduling clinic visit take consideration time Standard Care ( SOC ) visit . Alternative arrangement may make enable subject schedule home nurse visit study procedure instead certain clinic visit . Remaining blood urine aliquot store may use future discovery , analysis , verification and/or validation biomarkers test renal disease . The sample keep five year . Each sample identify 's barcode number individually identifiable .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephritis , Hereditary</mesh_term>
	<criteria>Able understand comply requirement study willing able provide write informed consent ; pediatric subject must able provide assent ; Age 1265 year age ; Confirmed diagnosis Alport syndrome ( clinical , histopathologic and/or genetic diagnosis Alport syndrome ) ; eGFR 4590 ml/min/1.73 m2 , within 30 day enrollment . Use investigational drug time enrollment , within 30 day , 5 halflives enrollment , whichever longer ; Ongoing chronic hemodialysis therapy and/or renal transplant recipient .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Alport syndrome</keyword>
	<keyword>kidney disease</keyword>
</DOC>